Global Research Antibodies Market

1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL RESEARCH ANTIBODIES MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY:
5.1 Western Blotting
5.2 Flow Cytometry
5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
5.4 Immunohistochemistry
5.5 Immunofluorescence
5.6 Immunoprecipitation
5.7 Other Technologies

6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER:
6.1 Pharmaceutical and Biotechnology Companies
6.2 Academic and Research Institutes
6.3 Contract Research Organizations

7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT:
7.1 Reagents
7.1.1 Media & Sera
7.1.2 Stains & Dyes
7.1.3 Fixatives
7.1.4 Buffers
7.1.5 Solvents
7.1.6 Enzymes
7.1.7 Probes
7.1.8 Other Reagents
7.2 Antibodies
7.2.1 By Type
7.2.1.1 Primary Antibodies
7.2.1.2 Secondary Antibodies
7.2.2 By Source
7.2.2.1 Mice
7.2.2.2 Rabbits
7.2.2.3 Other Sources
7.2.3 By Research Area
7.2.3.1 Oncology
7.2.3.2 Infectious Diseases
7.2.3.3 Immunology
7.2.3.4 Neurobiology
7.2.3.5 Stem Cells
7.2.3.6 Other Research Areas

8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION:
8.1 Proteomics
8.2 Drug Development
8.3 Genomics

9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL RESEARCH ANTIBODIES MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Thermo Fisher Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Merck Group
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Abcam PLC
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Becton, Dickinson and Company
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Cell Signaling Technology, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Bio-Rad Laboratories, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 F. Hoffmann-La Roche Ltd
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Agilent Technologies, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Danaher Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Lonza
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Genscript
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Perkinelmer, Inc.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Biolegend, Inc.
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

12 Appendix
12.1 Related Reports